Convalescent Plasma for the Treatment of Patients With Severe COVID-19 Infection

NCT04408209 · clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
60
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

National and Kapodistrian University of Athens

Collaborators